Q2 2022
Read transcript →KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$0.11
-4.44%
Mkt Cap $5.69M
Q1 2022
Read transcript →Q4 2021
Read transcript →Q3 2021
Read transcript →Q2 2021
Read transcript →Q1 2021
Read transcript →Q4 2020
Read transcript →Q3 2020
Read transcript →Q2 2020
Read transcript →Q1 2020
Read transcript →Q4 2019
Read transcript →Q3 2019
Read transcript →Q2 2019
Read transcript →Q1 2019
Read transcript →Q4 2018
Read transcript →Q4 2017
Read transcript →